ClinicalMetric Research Team · Last Reviewed: July 2026 · Sources: ClinicalTrials.gov · FDA · NIH
◆ Clinical Trial Intelligence — Key Facts
  • 400,000+ active trials registered on ClinicalTrials.gov across 200+ countries (2025)
  • Only ~12% of drugs entering clinical trials ultimately receive FDA approval
  • Average clinical trial takes 6–13 years from Phase 1 to regulatory approval
  • ~40% of trials fail to recruit sufficient participants — the #1 reason trials stop early
  • All trials must register on ClinicalTrials.gov under the FDA Amendments Act (FDAAA 2007)
← Back to Insights
Patient Guide Last Reviewed: July 2026 CM-INS-146 // JUNE 2026

The Real Cost of Joining a Clinical Trial: What Insurance Covers and What You Pay

"The trial is free" is one of the most common — and most misleading — things patients are told. It's true in a narrow sense: the investigational drug itself, and the extra tests done purely for research, are almost always paid for by the study's sponsor. But a clinical trial is not just a drug. It's months of office visits, blood draws, scans, and sometimes hospital stays — and a large share of that is billed as ordinary medical care, to you and your insurer, exactly as it would be if you weren't in a trial at all. The patients who get blindsided by a bill are almost never surprised by the drug. They're surprised by the parking, the travel, the specialist copays, and the one CT scan that a billing system decided was "routine care" rather than "research."

Medical Notice

This article is for informational purposes only and does not constitute medical or financial advice. Coverage rules vary by plan, state, and trial. Always confirm specifics with your insurer, the study team, and a qualified professional.

Summary

Clinical trial costs split into two buckets. "Research costs" — the investigational drug, study-specific tests, and research staff time — are paid by the sponsor. "Routine costs" — the standard care you'd receive anyway — are billed to your insurance, and since 2014 the Affordable Care Act has required most health plans to cover the routine costs of participating in an approved clinical trial for a life-threatening or other serious condition. Medicare has covered qualifying trial routine costs since 2000. But coverage is not the same as free: your normal deductibles, copays, and coinsurance still apply, and non-medical costs like travel and lost wages usually fall entirely on you. Understanding which bucket each item lands in — before you enroll — is how you avoid a surprise bill.

ClinicalMetric Analysis

  • The single most valuable document you can ask for is the trial's "billing plan" or "coverage analysis" — and most patients never know it exists. Before a trial opens, the research site prepares a document that classifies every procedure in the protocol as either a research cost (sponsor pays) or a routine cost (billed to insurance). This coverage analysis is the definitive map of who pays for what. Asking the study coordinator "can you walk me through the coverage analysis for this protocol?" signals that you understand the system and gets you a far more precise answer than "is the trial free?"
  • The ACA's clinical trial provision protects your access to a trial, not your wallet. The law bars an insurer from dropping you or denying the routine care you'd otherwise get just because you enrolled in a qualifying trial — a real and important protection. But it does nothing to your deductible, copays, or coinsurance, and it does not obligate the insurer to pay for the investigational drug or research-only procedures. Patients who read "insurance must cover clinical trials" as "clinical trials cost me nothing" are conflating two very different things.
  • Non-medical costs are the ones that quietly sink participation — and the ones most likely to be reimbursable if you ask. Travel to a distant academic center, lodging, parking, meals, childcare, and lost income are rarely covered by insurance, yet they're often the deciding factor in whether a patient can complete a trial. What many patients don't realize is that a growing number of sponsors now offer stipends or reimbursement for exactly these costs, and IRBs have become more comfortable approving them. If the consent form is silent on travel support, ask directly — the answer is increasingly yes.

The Two Buckets: Research Costs vs. Routine Costs

Almost every question about trial cost comes down to which of two categories a given item falls into. Getting this distinction clear removes most of the confusion.

Research costs — the sponsor pays

These are the costs that exist only because the study exists. They include the investigational drug or device itself; any test, scan, or procedure done solely to collect research data (an extra biopsy, additional blood draws for pharmacokinetic analysis, a specialized imaging study the protocol requires beyond standard care); the time of the research coordinators and study staff; and the data management that supports the trial. You should never be billed for these, and if you are, it is an error to flag immediately with the study team.

Routine costs — your insurance is billed

These are the costs of care you would have received anyway, in the ordinary course of treating your condition, whether or not you joined a trial. Office visits, standard-of-care imaging, routine bloodwork, the treatment of side effects, hospitalization for a complication — these are billed to your insurance like any other care. This is where your deductible and copays apply, and it is the category the Affordable Care Act's clinical trial provision was written to protect.

What the Law Actually Requires

Two overlapping frameworks govern routine-cost coverage in the United States.

The Affordable Care Act (private and marketplace plans)

Since January 2014, the ACA has required most group and individual health plans to cover the routine patient costs of participating in an "approved clinical trial" for the treatment of cancer or another life-threatening disease, and prohibits plans from dropping or limiting a member because they chose to participate. "Approved" trials include federally funded studies, trials conducted under an FDA investigational new drug application, and certain others. Grandfathered plans that predate the ACA are exempt, which is one reason confirming your specific plan matters.

Medicare

Under a national coverage determination in effect since 2000, Medicare covers the routine costs of qualifying clinical trials, along with the care needed to diagnose and treat complications arising from trial participation. Medicare does not pay for the investigational item itself or for research-only services.

Medicaid

Medicaid coverage of routine trial costs historically varied by state, but the Consolidated Appropriations Act of 2021 required state Medicaid programs, effective 2022, to cover routine patient costs for qualifying clinical trials — closing a long-standing gap for lower-income participants.

The common thread: all three frameworks cover routine costs and none of them obligate anyone but the sponsor to cover the research costs. And none of them waive your ordinary cost-sharing.

The Hidden Costs Patients Underestimate

The bills that cause the most distress are usually the ones nobody discussed at enrollment. Watch for these:

  • Your normal cost-sharing on routine care. If your plan has a $3,000 deductible and 20% coinsurance, a trial that intensifies your visit and imaging schedule can push you toward your out-of-pocket maximum faster than usual — all legitimately billed.
  • Travel and lodging. Many trials, especially for rare conditions, run at a handful of academic centers. Repeated trips, overnight stays, parking, and meals add up quickly and are rarely covered by insurance.
  • Lost wages and time. Trial visits are frequent and can be long. Time away from work — for you and for a caregiver who accompanies you — is a real and often unreimbursed cost.
  • Out-of-network billing. If the trial site is outside your insurer's network, routine costs billed there may be subject to higher out-of-network rates. Confirm the site's network status with your plan.
  • Miscategorized items. Occasionally a research-only procedure is mistakenly billed to insurance, or a routine item is delayed while billing is sorted out. Keep every explanation of benefits and reconcile it against the coverage analysis.

How to Protect Yourself Before Enrolling

  • Ask for the coverage analysis. Request a plain-language walkthrough of which procedures the sponsor pays for and which are billed to insurance. This is the single most clarifying step.
  • Call your insurer with the trial's details. Give them the trial name, sponsor, and site, and ask specifically whether it is a "qualifying clinical trial" under your plan and whether the site is in-network.
  • Ask about travel and financial support. Inquire whether the sponsor offers stipends, travel reimbursement, or lodging assistance, and whether the site has a financial navigator or social worker.
  • Confirm who pays for complications. Ask, in writing, who is responsible if you experience a serious side effect requiring hospitalization — and whether the sponsor's injury-compensation provision has any cap.
  • Keep meticulous records. Save the consent form, the coverage analysis, and every EOB. If a research cost is billed to you in error, the paper trail is how you get it reversed quickly.

Key Takeaways

  • Trial costs divide into research costs (sponsor pays: the investigational drug and study-only tests) and routine costs (billed to insurance: care you'd receive anyway).
  • The ACA, Medicare, and — since 2022 — Medicaid all require coverage of routine costs for qualifying trials, but none waive your deductible, copays, or coinsurance.
  • "The trial is free" usually refers only to the drug and research procedures — not to the surrounding standard care or your normal cost-sharing.
  • Non-medical costs — travel, lodging, lost wages — are the most underestimated and least insured, but are increasingly reimbursable by sponsors if you ask.
  • Request the trial's coverage analysis and confirm your plan's rules before enrolling; it is the clearest defense against a surprise bill.

Frequently Asked Questions

Is the investigational drug always free?

In a clinical trial, the investigational drug is almost always provided at no cost by the sponsor — that is one of the defining features of a trial. This is different from expanded access (compassionate use) outside a trial, where a manufacturer is permitted to charge cost-recovery. Within a formal interventional trial, you should not be billed for the study drug itself. If you ever see the investigational agent on a bill, raise it with the study coordinator immediately, as it is likely a billing error.

Will joining a trial affect my insurance premiums or coverage?

Under the Affordable Care Act, a health plan cannot drop you, deny you, or limit your coverage simply because you chose to participate in a qualifying clinical trial, and it cannot deny the routine care you would otherwise receive. Participation does not raise your premium. What it does not change is your existing plan structure — your deductible, copays, and coinsurance continue to apply to routine costs exactly as they normally would.

Do participants get paid to be in a trial?

It depends on the trial. Healthy-volunteer studies (common in Phase 1) frequently pay participants for their time and inconvenience, sometimes substantially. Trials in patients with a disease more often reimburse costs — travel, lodging, parking — rather than paying for participation, since payment that is large enough to influence a sick patient's decision raises ethical concerns about undue inducement. IRBs review any payment to ensure it compensates without coercing. Ask the study team what, if any, compensation or reimbursement the trial offers.

What if my insurance denies a routine cost the trial says it should cover?

Start with the study site's financial navigator or research billing office — they handle these disputes routinely and can provide documentation that the service is a covered routine cost of a qualifying trial. If the denial stands, you have the right to appeal through your insurer's formal appeals process, and the ACA's protections for qualifying trials give you a strong basis. Keep the coverage analysis, the consent form, and the explanation of benefits together; that paper trail is what resolves most disputes.

◆ Primary Sources & Further Reading
National Cancer Institute — Paying for Clinical Trials CMS — Medicare Clinical Trial Policies

Related Articles

Patient Guide
Clinical Trial Compensation & Payment
Patient Guide
How to Join a Clinical Trial
Patient Guide
Decentralized & Remote Clinical Trials
EK
◆ Founder & Platform Director
Efi Kara
Electrical & Computer Engineer · 30 years IT management · responsible for platform implementation, editorial direction, and growth strategy.
◆ Research & Analysis
IA
Ioannis Anagnostopoulos
Clinical Research Analyst & ISO Inspector

B.Sc. Agricultural Sciences. ISO inspector and compliance auditor. Researches and writes ClinicalMetric Insights using primary sources: ClinicalTrials.gov, FDA, EudraCT, PubMed.

📅 Last reviewed: 2026-06-27
◆ Medical Review
GA
Georgios Anagas
Medical Content Reviewer

Physiotherapy student. Reviews Insights articles for medical accuracy and patient relevance — condition descriptions, eligibility language, and treatment context for patients and caregivers.

⚕️ Patient-facing medical accuracy review
◆ Technical Review
AA
Achi Anagas
Platform & Data Infrastructure Lead

B.Sc. Informatics & Communications (in progress). Responsible for ClinicalMetric's technical architecture, API integrations with ClinicalTrials.gov, and data accuracy verification.

🔄 Trial data updated daily from ClinicalTrials.gov
◆ Editorial & Research Standards
Stage 1 — Primary Research
ClinicalTrials.gov registry data (NIH/NLM), FDA documentation, EudraCT, and peer-reviewed literature. Trial status, phase, eligibility, and enrollment data verified at source.
Stage 2 — Medical Accuracy Review
Cross-checked against PubMed/MEDLINE literature and FDA/EMA communications. Eligibility criteria and patient safety information verified for accuracy.
Stage 3 — Registry Verification
Phase classification, enrollment status, sponsor identity, and trial location cross-referenced against official registry records before publication.
⚕️ Medical Disclaimer: ClinicalMetric provides research intelligence only. Always consult a qualified healthcare provider before making clinical decisions or participating in a trial.
Publisher
ClinicalMetric
Independent Clinical Trial Intelligence
Tracks 400,000+ active clinical trials worldwide. Updated daily from ClinicalTrials.gov (NIH/NLM), FDA IND registry, and EudraCT (EU Clinical Trials Register).
Research Methodology
Articles are researched from primary registry sources: ClinicalTrials.gov XML feeds, FDA trial databases, and peer-reviewed literature. Trial status, phase, enrollment, and eligibility data is sourced directly from registry APIs — not secondary aggregators.
Primary Data Sources
Accuracy & Updates
Trial status, enrollment, and eligibility information changes frequently. ClinicalMetric syncs with ClinicalTrials.gov daily. Editorial articles are reviewed quarterly or when major protocol amendments are published. Always verify trial status directly on ClinicalTrials.gov before making clinical decisions.
◆ Live Clinical Trial Feed
Browse 400,000+ Active Clinical Trials
Updated daily from ClinicalTrials.gov · Recruiting trials by condition, phase, sponsor
Search Active Trials →
About ClinicalMetric → Research Methodology → Medical Disclaimer → LinkedIn →

Browse Recruiting Clinical Trials

Find active recruiting trials on ClinicalMetric — updated daily from ClinicalTrials.gov.

Browse by Condition →Phase 3 TrialsAll Recruiting Trials

Editorial Notice: This article was reviewed by the ClinicalMetric editorial team. Clinical trial data changes frequently as trials progress, enroll, or close. Nothing on this site constitutes medical advice — always consult a qualified healthcare professional. To report an inaccuracy, contact dev@clinicalmetric.com.

◆ Related Research Guides
Trial DesignAdaptive Clinical Trial Design 2026: Seamless Phases, Response-Adaptive Randomization, and Platform TrialsRead guide →Patient GuideAdverse Events Explained: How Side Effects Are Tracked, Graded, and ReportedRead guide →Data ScienceAI in Clinical Data Management 2026: EDC, Risk-Based Monitoring, and eTMF AutomationRead guide →PulmonologyAsthma Clinical Trials 2026: Biologics for Severe Asthma & New TreatmentsRead guide →
ClinicalMetric Intelligence Team
Clinical Trial Research & Analysis · Last updated April 2026
Analysis compiled from ClinicalTrials.gov (NIH/NLM), FDA trial registry data, and peer-reviewed clinical research. ClinicalMetric tracks 400,000+ active clinical trials worldwide, updated daily from the ClinicalTrials.gov AACT database.
Get Weekly Clinical Trial Alerts
New recruiting trials from NIH, NCI, and 40+ sponsors — every Monday. Free forever.
◆ Clinical Trial Intelligence at a Glance
400K+
Active trials tracked
200+
Countries with active trials
4
Clinical trial phases
Daily
Data refresh from ClinicalTrials.gov
◆ Clinical Trial Phase Transition Success Rates
Phase 1 → Phase 2 success ~63%
Phase 2 → Phase 3 success ~32%
Phase 3 → Approval ~58%
Overall FDA approval rate ~12%
Source: Biotechnology Innovation Organization (BIO) Clinical Development Success Rates — approximate industry averages.
◆ Clinical Trial Development Timeline
Mo 1–6
Preclinical + IND Filing
Mo 6–18
Phase 1 (Safety)
Mo 18–48
Phase 2 (Efficacy)
Mo 48–84
Phase 3 (Pivotal)
Mo 84–96
FDA Review / NDA
Mo 96+
Approval + Phase 4
Timeline is approximate. Total development from preclinical to approval averages 6–13 years.
About the Author
ClinicalMetric Research Team
Clinical Trial Intelligence Specialists · clinicalmetric.com
Our analysts monitor 400,000+ clinical trials daily across oncology, neurology, cardiology, and rare diseases. All data sourced from ClinicalTrials.gov and FDA.gov.
🔬 400K+ trials tracked 🌍 200+ countries 🔄 Updated: July 2026
◆ Common Questions About Clinical Trials
What is a clinical trial? +
A clinical trial is a research study involving human participants designed to evaluate medical interventions — such as drugs, devices, or behavioral strategies. Trials follow a structured protocol and are registered on ClinicalTrials.gov. They progress through phases: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale comparison), and Phase 4 (post-market surveillance).
How do I find clinical trials I'm eligible for? +
You can search ClinicalTrials.gov or use ClinicalMetric to filter by condition, phase, or location. Each trial listing includes eligibility criteria such as age range, sex, diagnosis, and prior treatment history. Contact the study team directly or ask your physician to refer you to a relevant trial.
Are clinical trials safe to participate in? +
Clinical trials are conducted under strict ethical and regulatory oversight, including IRB approval and FDA regulation in the US. All participants must give informed consent after reviewing potential risks and benefits. Phase 1 trials carry more uncertainty, while Phase 3 trials involve interventions with an established safety profile. Participation is always voluntary and you may withdraw at any time.
What are the phases of clinical trials? +
Clinical trials progress through four main phases. Phase 1 tests safety and dosing in a small group (20–80 people). Phase 2 evaluates efficacy and side effects in a larger group (100–300). Phase 3 compares the intervention against standard treatments in thousands of participants. Phase 4 occurs after approval and monitors long-term effects in the general population.
Do participants get paid for joining clinical trials? +
Many clinical trials offer compensation for time and travel expenses, though payment structures vary widely by study. Compensation is not intended to be coercive. Some trials also cover treatment costs for participants. Always review the consent form carefully and ask the study coordinator about any financial considerations before enrolling.
Browse by Phase
Phase 1Phase 2Phase 3Phase 4
Browse by Condition
CancerDiabetesAlzheimer'sDepressionHeart DiseaseCOVID-19Parkinson'sMultiple Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology